https://www.selleckchem.com/btk.html
Secondary outcomes may include the individual components of the primary outcome, length of hospitalisation, serious adverse events, and health care resource utilisation. The proposed endpoint may help move the GIB field forward by focusing on the most clinically relevant outcomes for patients with acute GIB of all types and informing study design and importance of sample size determination for future RCTs in GIB. The proposed endpoint may help move the GIB field forward by focusing on the most clinically relevant outcomes for patients with acute GIB